Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
mFluiDx logo — point-of-care molecular diagnostics

mFluiDx

point-of-care molecular diagnostics

Founded 2016 United States Oakland, United States 1 employees Non Equity Assistance Biotechnology, Health Care

General Information

Company Name mFluiDx
Founded Year 2016
Location United States Oakland, United States
Employees 1
Industries Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with mFluiDx. To contact mFluiDx, visit mfluidx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does mFluiDx compare?

A PDF of mFluiDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting mFluiDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About mFluiDx

mFluiDx is a biotechnology startup focused on point-of-care molecular diagnostics. Founded in 2016 as a spinout from UC Berkeley, the company has been dedicated to developing innovative technology for rapid and low-cost molecular DNA/RNA diagnostics. Their efforts are particularly noteworthy within the health care sector, aiming to revolutionize the way diagnostics are conducted.

The company's recent funding has seen support from Berkeley SkyDeck, receiving a Non Equity Assistance investment on 01 March 2020. This backing underscores the confidence of notable investors in mFluiDx's potential and the significance of their technology in transforming molecular diagnostics at the point-of-care.

mFluiDx's dedication to developing cutting-edge solutions in the United States positions them as a strong contender in the biotechnology and health care industries, showcasing potential for significant impact and growth in the near future.

Business keywords: molecular diagnostics, point-of-care testing, UC Berkeley spinout, DNA diagnostics, RNA diagnostics, Zika Virus, Dengue Fever, global pandemics, field-based diagnostics, rapid diagnostics, low-cost diagnostics, innovative technology, self-powered disposable chip, startup

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Berkeley SkyDeck
Berkeley SkyDeck
01 Mar 2020
Venture Round Undisclosed 1
Cthulhu Ventures
Cthulhu Ventures
01 Jan 2020
Seed Round Undisclosed 2
SOSV indiebio
SOSV, indiebio
08 Mar 2016

mFluiDx Alternatives & Competitors

View All Alternatives
mFluiDx vs
GlowDx
GlowDx Ireland

Acceso al diagnóstico para todos.

Seed
26 employees
Biotechnology, Health Care
mFluiDx vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
mFluiDx vs
LSK Technologies Inc. (Now part of Nicoya)
LSK Technologies Inc. (Now part of Nicoya) Canada

Lab-Quality Testing Without the Lab: Affordable Solutions for Fast and Accurate Results

Seed
2 employees
Biotechnology, Digital Health
Also compare with: mFluiDx vs DiagCor Life Science Limited DiagCor Life Science Limited View all alternatives

FAQ About mFluiDx

point-of-care molecular diagnostics
mFluiDx was founded in 2016.
mFluiDx is headquartered in Oakland, United States.
mFluiDx operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, point-of-care testing, UC Berkeley spinout and DNA diagnostics.
mFluiDx has approximately 1 employees.
mFluiDx has completed 3 funding rounds. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to mFluiDx include GlowDx, EMPE Diagnostics, LSK Technologies Inc. (Now part of Nicoya), InSilixa, Tinoro, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
mFluiDx and GlowDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for mFluiDx, https://bouncewatch.com/company/mfluidx, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes